1. Microfluidic 3D bioprinting technology – Receive in-kind access to our microfluidic 3D bioprinting platform in your lab for the duration of your project.
2. Scientific support – Receive support from our internal team of tissue engineering experts.
3. Pathway to the clinic – Translate your research to the clinic by working with a partner who has a deep biopharma and VC network and is committed to commercializing therapeutics. 
4. Funding support – Benefit from grant co-applications and support.
5. A collaborative network – Engage in the Discovery Ecosystem: a global network of academic partners using our technology to develop impactful applications.

We are seeking to support academic researchers who are:

1. Actively working towards cell-based therapeutic applications
2. Focused on translation and committed to seeing research through to commercialization
3. Innovative and knowledgeable, with strong biological and domain-specific expertise
4. Open to adopting innovative technology to advance their research
5. Well-equipped to achieve the research objectives for this project

• Talk to us about your work and find out more about what we do.
• Submit a proposal for our Bioprinting Technology Grant to tell us about your research project.
• Our Academic Partnerships team will evaluate your application and get in touch.

At Aspect, we are developing a targeted pipeline of bioprinted therapeutics to make people healthier. But there are so many other opportunities to address unmet medical need.

We launched the Bioprinting Technology Grant in order to:

1. Expand the application of our technology to more therapeutic areas
2. Generate publications to contribute to the ocean of knowledge required for therapeutic development
3. Accelerate the creation of new commercial pathways to get to the clinic faster

You/your institution retain the intellectual property developed during the project and Aspect has the option to negotiate a license to commercialize by leveraging our expertise and deep biopharma and VC network.

By combining your expertise with our technology platform and scientific and commercialization support, we believe that we can bring a greater number of innovative bioprinted therapeutics to the clinic, faster.